Drug Search Results
More Filters [+]

Nizatidine

Alternative Names: nizatidine, axid, axid ar, nizatidin, nizax
Latest Update: 2024-12-19
Latest Update Note: Clinical Trial Update

Product Description

Nizatidine is used to treat and prevent the recurrence of ulcers and to treat other conditions where the stomach makes too much acid. Nizatidine also is used to treat or prevent occasional heartburn, acid indigestion, or sour stomach. It decreases the amount of acid made in the stomach. (Sourced from: https://medlineplus.gov/druginfo/meds/a694030.html)

Mechanisms of Action: H2 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Bangladesh | Brazil | Bulgaria | Canada | Chile | Colombia | Denmark | Egypt | France | Germany | India | Ireland | Italy | Korea | New Zealand | Pakistan | Peru | Portugal | Saudi Arabia | Sweden | Taiwan | Turkey | United Arab Emirates | United Kingdom | United States | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Nizatidine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events